Product Approvals, Delays, & Disappointments
The PharmaTell team had Eyes on new products this week – watching Lilly’s Mounjaro approval, UBS’s Bimzelx CRL, and Roche’s SKYSCRAPER-1 data.
May 15, 2022
Eyes on Pharma
We’re keeping our Eyes on Pharma – tracking the latest happenings in Healthcare. Join us each week on the PharmaTell Blog as we highlight a few of the trending topics in PharmaTell Studio.
Quarterly Results, Biogen, & Conference Planning
The PharmaTell Team has been busy this week curating Quarterly Results Reports & upcoming conference planners + keeping up with Biogen next steps.
May 8, 2022
AACR Updates & CAR-T Overview
This week the team has been enjoying the Spring Holidays, Reviewing the AACR Highlights, and Learning about CAR-T.
April 20, 2022
Patient Volumes Recovering + Aduhelm
This week we had Eyes on Patient Volumes – post-COVID recovery + the CMS Final say on Aduhelm Coverage.
April 9, 2022
PharmaTell Studio Upgrades
This week we want to share the latest upgrades to PharmaTell Studio. As always we are innovating to help you keep your eyes on you & your competition.
April 4, 2022
FDA Approvals, Transcripts, & Conferences
This week the team has been looking at congress planners, transcripts, and the US FDA.
March 27, 2022